Skip to main content
Top
Published in: BMC Medical Informatics and Decision Making 1/2012

Open Access 01-12-2012 | Research article

Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: A population-based survey

Authors: Charlotte Gry Harmsen, Henrik Støvring, Dorte Ejg Jarbøl, Jørgen Nexøe, Dorte Gyrd-Hansen, Jesper Bo Nielsen, Adrian Edwards, Ivar Sønbø Kristiansen

Published in: BMC Medical Informatics and Decision Making | Issue 1/2012

Login to get access

Abstract

Background

Shared decision-making and patients’ choice of interventions are areas of increasing importance, not least seen in the light of the fact that chronic conditions are increasing, interventions considered important for public health, and still non-acceptance of especially risk-reducing treatments of cardiovascular diseases (CVD) is prevalent. A better understanding of patients’ medication-taking behavior is needed and may be reached by studying the reasons why people accept or decline medication recommendations. The aim of this paper was to identify factors that may influence people’s decisions and reasoning for accepting or declining a cardiovascular preventive medication offer.

Methods

From a random sample of 4,000 people aged 40–59 years in a Danish population, 1,169 participants were asked to imagine being at increased risk of cardiovascular disease and being offered a preventive medication. After receiving ‘complete’ information about effectiveness of the medication they were asked whether they would accept medication. Finally, they were asked about reasons for the decision.

Results

A total of 725 (67%) of 1,082 participants accepted the medication offer. Even quite large effects of medication (up to 8 percentage points absolute risk reduction) had a smaller impact on acceptance to medication than personal experience with cardiovascular disease. Furthermore, increasing age of the participant and living with a partner were significantly associated with acceptance. Some 45% of the respondents accepting justified their choice as being for health reasons, and they were more likely to be women, live alone, have higher income and higher education levels. Among those who did not accept the medication offer, 56% indicated that they would rather prefer to change lifestyle.

Conclusions

Medication effectiveness seems to have a moderate influence on people’s decisions to accept preventive medication, while factors such as personal experience with cardiovascular disease may have an equally strong or stronger influence, indicating that practitioners could do well to carefully identify the reasons for their patients’ treatment decisions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Edwards A, Elwyn G, Wood F, Atwell C, Prior L, Houston H: Shared decision making and risk communication in practice: a qualitative study of GPs' experiences. Br J Gen Pract. 2005, 55: 6-13.PubMedPubMedCentral Edwards A, Elwyn G, Wood F, Atwell C, Prior L, Houston H: Shared decision making and risk communication in practice: a qualitative study of GPs' experiences. Br J Gen Pract. 2005, 55: 6-13.PubMedPubMedCentral
2.
go back to reference Stacey D, Benneth CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Legare F, Thomson R: Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2011, 2: CD00143- Stacey D, Benneth CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Legare F, Thomson R: Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2011, 2: CD00143-
3.
go back to reference Barber N, Parsons J, Clifford S, Darracott R, Horne R: Patients' problems with new medication for chronic conditions. Qual Saf Health Care. 2004, 13: 172-175. 10.1136/qshc.2003.005926.CrossRefPubMedPubMedCentral Barber N, Parsons J, Clifford S, Darracott R, Horne R: Patients' problems with new medication for chronic conditions. Qual Saf Health Care. 2004, 13: 172-175. 10.1136/qshc.2003.005926.CrossRefPubMedPubMedCentral
5.
go back to reference Ross S, Walker A, MacLeod MJ: Patient compliance in hypertension: role of illness perceptions and treatment beliefs. J Hum Hypertens. 2004, 18: 607-613. 10.1038/sj.jhh.1001721.CrossRefPubMed Ross S, Walker A, MacLeod MJ: Patient compliance in hypertension: role of illness perceptions and treatment beliefs. J Hum Hypertens. 2004, 18: 607-613. 10.1038/sj.jhh.1001721.CrossRefPubMed
6.
go back to reference Barry CA, Bradley CP, Britten N, Stevenson FA, Barber N: Patients' unvoiced agendas in general practice consultations: qualitative study. BMJ. 2000, 320: 1246-1250. 10.1136/bmj.320.7244.1246.CrossRefPubMedPubMedCentral Barry CA, Bradley CP, Britten N, Stevenson FA, Barber N: Patients' unvoiced agendas in general practice consultations: qualitative study. BMJ. 2000, 320: 1246-1250. 10.1136/bmj.320.7244.1246.CrossRefPubMedPubMedCentral
7.
go back to reference Britten N, Stevenson FA, Barry CA, Barber N, Bradley CP: Misunderstandings in prescribing decisions in general practice: qualitative study. BMJ. 2000, 320: 484-488. 10.1136/bmj.320.7233.484.CrossRefPubMedPubMedCentral Britten N, Stevenson FA, Barry CA, Barber N, Bradley CP: Misunderstandings in prescribing decisions in general practice: qualitative study. BMJ. 2000, 320: 484-488. 10.1136/bmj.320.7233.484.CrossRefPubMedPubMedCentral
8.
go back to reference Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol. 2004, 44: 720-732. 10.1016/j.jacc.2004.07.001.CrossRefPubMed Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol. 2004, 44: 720-732. 10.1016/j.jacc.2004.07.001.CrossRefPubMed
9.
go back to reference Stafford RS, Monti V, Ma J: Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease. PLoS Med. 2005, 2: e353-10.1371/journal.pmed.0020353.CrossRefPubMedPubMedCentral Stafford RS, Monti V, Ma J: Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease. PLoS Med. 2005, 2: e353-10.1371/journal.pmed.0020353.CrossRefPubMedPubMedCentral
10.
go back to reference Munger MA, Van Tassell BW, LaFleur J: Medication nonadherence: an unrecognized cardiovascular risk factor. MedGenMed. 2007, 9: 58-PubMedPubMedCentral Munger MA, Van Tassell BW, LaFleur J: Medication nonadherence: an unrecognized cardiovascular risk factor. MedGenMed. 2007, 9: 58-PubMedPubMedCentral
11.
go back to reference Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. 1995. Atheroscler Suppl. 2004, 5: 91-97.CrossRefPubMed Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. 1995. Atheroscler Suppl. 2004, 5: 91-97.CrossRefPubMed
12.
go back to reference Neutel CI, Morrison H, Campbell NR, de GM: Statin use in Canadians: trends, determinants and persistence. Can J Public Health. 2007, 98: 412-416.PubMed Neutel CI, Morrison H, Campbell NR, de GM: Statin use in Canadians: trends, determinants and persistence. Can J Public Health. 2007, 98: 412-416.PubMed
13.
go back to reference Stovring H, Gyrd-Hansen D, Kristiansen IS, Nexoe J, Nielsen JB: Communicating effectiveness of intervention for chronic diseases: what single format can replace comprehensive information?. BMC Med Inform Decis Mak. 2008, 8: 25-10.1186/1472-6947-8-25.CrossRefPubMedPubMedCentral Stovring H, Gyrd-Hansen D, Kristiansen IS, Nexoe J, Nielsen JB: Communicating effectiveness of intervention for chronic diseases: what single format can replace comprehensive information?. BMC Med Inform Decis Mak. 2008, 8: 25-10.1186/1472-6947-8-25.CrossRefPubMedPubMedCentral
14.
go back to reference Gyrd-Hansen D, Halvorsen P, Nexoe J, Nielsen J, Stovring H, Kristiansen I: Joint and separate evaluation of risk reduction: impact on sensitivity to risk reduction magnitude in the context of 4 different risk information formats. Med Decis Making. 2011, 31: E1-E10.CrossRefPubMed Gyrd-Hansen D, Halvorsen P, Nexoe J, Nielsen J, Stovring H, Kristiansen I: Joint and separate evaluation of risk reduction: impact on sensitivity to risk reduction magnitude in the context of 4 different risk information formats. Med Decis Making. 2011, 31: E1-E10.CrossRefPubMed
15.
go back to reference Rosenstock IM: Historical origins of the Health Belief Model. The Health Belief Model and personal health behavior. Edited by: Becker MH. 1974, Thorofare, NJ: Charles B. Slack, Inc Rosenstock IM: Historical origins of the Health Belief Model. The Health Belief Model and personal health behavior. Edited by: Becker MH. 1974, Thorofare, NJ: Charles B. Slack, Inc
16.
go back to reference Edwards A, Elwyn G, Covey J, Matthews E, Pill R: Presenting risk information–a review of the effects of "framing" and other manipulations on patient outcomes. J Health Commun. 2001, 6: 61-82. 10.1080/10810730150501413.CrossRefPubMed Edwards A, Elwyn G, Covey J, Matthews E, Pill R: Presenting risk information–a review of the effects of "framing" and other manipulations on patient outcomes. J Health Commun. 2001, 6: 61-82. 10.1080/10810730150501413.CrossRefPubMed
17.
go back to reference Trewby PN, Reddy AV, Trewby CS, Ashton VJ, Brennan G, Inglis J: Are preventive drugs preventive enough? A study of patients' expectation of benefit from preventive drugs. Clin Med. 2002, 2: 527-533.CrossRef Trewby PN, Reddy AV, Trewby CS, Ashton VJ, Brennan G, Inglis J: Are preventive drugs preventive enough? A study of patients' expectation of benefit from preventive drugs. Clin Med. 2002, 2: 527-533.CrossRef
18.
go back to reference Gigerenzer G, Todd PM:Simple heuristics that make us smart. 1999, New York: Oxford University Press, Gigerenzer G, Todd PM:Simple heuristics that make us smart. 1999, New York: Oxford University Press,
19.
go back to reference Gigerenzer G, Gaissmaier W, Kurz-Milcke E, Schwartz LM, Woloshin S: Helping doctors and patients make sense of health statistics. Psychological Science in the Public Interest. 2007, 8: 53-96.PubMed Gigerenzer G, Gaissmaier W, Kurz-Milcke E, Schwartz LM, Woloshin S: Helping doctors and patients make sense of health statistics. Psychological Science in the Public Interest. 2007, 8: 53-96.PubMed
20.
go back to reference Wegwarth O, Gaissmaier W, Gigerenzer G: Smart strategies for doctors and doctors-in-training: heuristics in medicine. Med Educ. 2009, 43: 721-728. 10.1111/j.1365-2923.2009.03359.x.CrossRefPubMed Wegwarth O, Gaissmaier W, Gigerenzer G: Smart strategies for doctors and doctors-in-training: heuristics in medicine. Med Educ. 2009, 43: 721-728. 10.1111/j.1365-2923.2009.03359.x.CrossRefPubMed
Metadata
Title
Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: A population-based survey
Authors
Charlotte Gry Harmsen
Henrik Støvring
Dorte Ejg Jarbøl
Jørgen Nexøe
Dorte Gyrd-Hansen
Jesper Bo Nielsen
Adrian Edwards
Ivar Sønbø Kristiansen
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Medical Informatics and Decision Making / Issue 1/2012
Electronic ISSN: 1472-6947
DOI
https://doi.org/10.1186/1472-6947-12-89

Other articles of this Issue 1/2012

BMC Medical Informatics and Decision Making 1/2012 Go to the issue